Response by DeRubertis et al to Letter Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”

Brian G. DeRubertis; Sahil A. Parikh; Ramon L. Varcoe

doi:10.1161/circulationaha.126.079060

Response by DeRubertis et al to Letter Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”

B Brian G. DeRubertis (Division of Vascular and Endovascular Surgery, New York Presbyterian–Weill Cornell Medical Center, New York, NY (B.G.D.).) S Sahil A. Parikh R Ramon L. Varcoe (Division of Vascular Surgery, The Prince of Wales Hospital and University of New South Wales, Randwick, Australia (R.L.V.).)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 154, Issue 5

Published August 04, 2026

DOI 10.1161/circulationaha.126.079060

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (3)

B

Brian G. DeRubertis

Division of Vascular and Endovascular Surgery, New York Presbyterian–Weill Cornell Medical Center, New York, NY (B.G.D.).

S

Sahil A. Parikh

R

Ramon L. Varcoe

Division of Vascular Surgery, The Prince of Wales Hospital and University of New South Wales, Randwick, Australia (R.L.V.).

Response by DeRubertis et al to Letter Regarding Article, “Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial”

Article Details

Journal Info

Authors (3)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”